May 5, 2020 / 11:37 AM / 21 days ago

BRIEF-Xenleta Treatment Results In A Rapid Time-To-Clinical Response In Hospitalized Patients With Community-Acquired Bacterial Pneumonia

May 5 (Reuters) - Nabriva Therapeutics PLC:

* XENLETA® (LEFAMULIN) TREATMENT RESULTS IN A RAPID TIME-TO-CLINICAL RESPONSE IN HOSPITALIZED PATIENTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below